| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
David Patience is Chief Financial Officer at TLSI. David Patience's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $909K at current prices.
Net of sales, the TLSI filings show accumulation of 10,757 shares.
David Patience has 6 Form 4 filings on record from August 2025 to July 2026, all as Chief Financial Officer at TriSalus Life Sciences (TLSI), 2025–2026.
The 8 reported transactions were 3 option or other derivative awards, 2 open-market purchases, 2 stock awards and 1 tax withholding.
Counted by filing, the open-market trades come to 2 purchases worth about $32K and no sales.
The largest open-market purchase was 7,100 shares of TLSI at an average $2.43 on May 15, 2026, about $17K.